Literature DB >> 2896104

The effect of azelastine on exercise-induced asthma.

H Magnussen1, G Reuss, R Jörres, R Aurich.   

Abstract

In ten young asthmatic subjects, we studied the effect of a single oral dose of 4.4 mg of azelastine hydrochloride on exercise-induced bronchoconstriction during the breathing of cold air. Exercise challenges were performed on two different days before and four hours after azelastine and placebo given in a randomized double-blind crossover fashion. Placebo had no effect on baseline pulmonary function and postexertional obstruction of the airways, in contrast to azelastine, which exerted a small but significant (p less than 0.05) bronchodilation and a significant attenuation (p less than 0.01) of exercise-induced bronchoconstriction as compared to data from before treatment and after placebo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896104     DOI: 10.1378/chest.93.5.937

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Effect of cetirizine on exercise induced asthma.

Authors:  S K Ghosh; C De Vos; I McIlroy; K R Patel
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

2.  The effect of loratadine in exercise-induced asthma.

Authors:  A Baki; F Orhan
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

Review 3.  Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 4.  The antihistamines of the nineties.

Authors:  M M Janssens; P H Howarth
Journal:  Clin Rev Allergy       Date:  1993

5.  Role of histamine release in hypertonic saline induced bronchoconstriction.

Authors:  S P O'Hickey; N G Belcher; P J Rees; T H Lee
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

6.  Determination of Azelastine in Human Plasma by Validated Liquid Chromatography Coupled to Tandom Mass Spectrometry (LC-ESI/MS/MS) for the Clinical Studies.

Authors:  Yoo-Sin Park; Shin-Hee Kim; Young-Jae Kim; Seok-Chul Yang; Min-Ho Lee; Leslie M Shaw; Ju-Seop Kang
Journal:  Int J Biomed Sci       Date:  2010-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.